IberAmerican Lithium (NEOE:IBER) ROCE % : -184.48% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is IberAmerican Lithium ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IberAmerican Lithium's annualized ROCE % for the quarter that ended in Mar. 2024 was -184.48%.

IberAmerican Lithium ROCE % Historical Data

The historical data trend for IberAmerican Lithium's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IberAmerican Lithium ROCE % Chart

IberAmerican Lithium Annual Data

Trend

Dec21

Dec22

Dec23

ROCE %

-275.55

IberAmerican Lithium Quarterly Data
	Dec21	Mar22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial			-	-	-388.53	-125.20	-184.48

IberAmerican Lithium ROCE % Calculation

IberAmerican Lithium's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-4.362	/	( ( (0.309 - 1.041)	+	(4.345 - 0.447) )	/ 2 )
	=	-4.362	/	( (-0.732	+	3.898)	/ 2 )
	=	-4.362	/	1.583
	=	-275.55 %

IberAmerican Lithium's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-5.992	/	( ( (4.345 - 0.447)	+	(3.292 - 0.694) )	/ 2 )
	=	-5.992	/	( ( 3.898	+	2.598 )	/ 2 )
	=	-5.992	/	3.248
	=	-184.48 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

IberAmerican Lithium (NEOE:IBER) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

IberAmerican Lithium ROCE % Related Terms

Thank you for viewing the detailed overview of IberAmerican Lithium's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

IberAmerican Lithium (NEOE:IBER) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Metals & Mining » IberAmerican Lithium Corp (NEOE:IBER) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

IBRLF:USA

Address

3400 – 22 Adelaide S. W, Toronto, ON, CAN, M5H 4E3

Website

https://iberamericanlithium.com

IberAmerican Lithium Corp is engaged in the acquisition and exploration of mineral resource properties in Spain, namely its lithium exploration project beneficially owned and controlled by its subsidiary.

Executives

Serafino Iacono

10% Security Holder, Director

IberAmerican Lithium (NEOE:IBER) Headlines

From GuruFocus

Ibere Pharmaceuticals Announces Closing of $138,000,000 Initial Public Offering

By PRNewswire PRNewswire • 03-03-2021

Ibere Pharmaceuticals Receives Expected NYSE Notice Regarding Delayed Quarterly Report

By PRNewswire PRNewswire • 05-28-2021